Global Wilsons Disease Treatment Market – Size, Share and Forecast (2019-2026)

SKU: DPH66 | Published On: | Available Formats

Wilson’s Disease Treatment Market

  • The global Wilson’s disease treatment market is expected to grow at a CAGR of XX% to reach a market value of USD XX million by 2026.
  • Wilson disease is a genetic disorder that prevents the removal of extra copper in the body. Without treatment, the disease can cause life-threatening organ damage due to the copper built up in the liver, eyes, brain, and other organs.
  • The diagnose of Wilson disease is based on family history, physical exams, an eye exam, blood tests, and urine tests. Liver biopsy and imaging tests may also be used.
  • Treatment of Wilson disease is done with medication such as zinc. Patients who have Wilson disease need lifelong surgery to manage symptoms to reduce or prevent organ damage. Wilson’s disease can cause acute liver failure which may lead to the need for a liver transplant.

 

Wilson’s Disease Treatment Market Dynamics

  • The global market for Wilson’s disease Treatment is primarily driven by the financial incentives and overall rewards for the successful development of drugs for the treatment and diagnosis of rare diseases and conditions.
  • Moreover, the increasing awareness regarding Wilson’s disease by various organization and association and its symptoms along with the growing population all over the world is expected to fuel the treatment market.
  • For instance, Wilson’s disease association, a volunteer organization strives to promote the latest information about Wilson’s disease and support research and clinical investigation for the illness.
  • Wilson disease is found worldwide, with an estimated prevalence of 1 case per 30,000 live births in most populations and approximately one person in 90 carries an abnormal copy of the ATP7B gene, which causes the diseases.
  • However, the high initial investments resulting in higher per patient treatment cost may hinder the market progress.

 

Wilson’s Disease Treatment Market Segmentation Analysis

  • By Indication, the Global Wilson’s Disease Treatment Market is segmented into Hepatic, Neuropsychiatric, Ophthalmic, and others (heart and kidney complications).
  • The Hepatic indications are diagnosed in Wilson’s disease as the reduced biliary excretion of copper results in an excessive accumulation of copper in the liver.
  • The early symptoms are manifested in the liver as tiredness, hepatitis and suddenly develop acute liver failure. According to the European Association for the study of the liver, an estimated 6-12% of people having acute liver failure are affected by Wilson’s disease.
  • The neuropsychiatric indications are manifested in the later stages of the disease manifestation persistent neurological problems such as Parkinsonism, tremors, and seizures. Involuntary muscle movements, tremors, clumsy gait and speech difficulties may improve with treatment for Wilson’s disease.
  • In approximately 90 % of the patients exhibiting neuropsychiatric symptoms shows the development of Kayser-Fleischer rings (deposition of copper) in the cornea region of the eyes.
  • By Treatment, the Global Wilson’s Disease Treatment Market is segmented into medication and others. Medication share is future sub-segmented into D-Penicillamine, Trientine, Zinc, and Tetrathiomolybdate. Currently, chelators are the first line of treatment for achieving symptomatic relief. Penicillamine and trientine are two chelating agents used to treat Wilson disease. These medicines deplete the excessive copper levels from the body.
  • However, the side-effects associated with chelators are severe such as bone marrow suppression and kidney complications thus hampering its market growth. Zinc acetate is recommended as an alternative therapy to chelators.
  • However, its effect is prolonged hence used for maintenance therapy only.

 

Wilson’s Disease Treatment Market Geographical Analysis

  • North America is the dominant share followed by Europe in the global Wilson’s disease treatment market, and it is primarily attributed to factors such as rapid growth in the geriatric population in these regions.
  • Being an orphan disease, the European Medical Agency is proactively investing in the novel drug discovery for Wilson’s disease. Moreover, the established healthcare infrastructure and the rising disposable income and higher investment in R&D activities contribute to the growth of North America’s share.
  • According to a countrywide survey by U.S. Department of Health and Human Services, 2015, the prevalence of Wilson’s disease in the United States is 1 in 55,000 births with Wilson’s disease an allele frequency of 0.428%.
  • Asia-Pacific region is expected to be the fastest growing market during the forecast period, owing to the region’s increasing population in countries such as China and India.
  • This makes the area highly lucrative markets for Wilson’s disease treatment. The region’s rapidly improving healthcare infrastructure, the rise in healthcare expenditure, and the increasing awareness of Wilson’s disease also boost the market.
  • The market is deeply dependent on imported drugs from the U.S. and Europe which creates an opportunity for the current generic market in the Asia Pacific.

 

Wilson’s Disease Treatment Market Competitive Analysis

  • Key players are adopting strategies such as mergers and acquisitions, partnerships, and regional expansion along with an increased focus on R&D to stand out as strong competitors in the market.
  • May 2018, Alexion Pharmaceuticals announced that its offer to acquire all its outstanding shares through a wholly-owned subsidiary of Wilson Therapeutics had been accepted Wilson Therapeutics is a biopharmaceutical company, based in Sweden, that develops novel therapies for patients with Wilson’s disease. Wilson Therapeutics’ product, WTX101, is in Phase 3 development as a treatment for Wilson diseases.
  • February 2018, Teva Pharmaceuticals announced the release of a generic version of Syprine (trientine hydrochloride) capsules, 250 mg, as a substitute treatment for Wilson’s disease in the United States.
  • December 2017, Wilson Therapeutics AB announced that the U.S. Food and Drug Administration (FDA) granted WTX101 Fast Track designation for the treatment of Wilson Disease. WTX101 (bis-choline tetrathiomolybdate) is a first-in-class copper-protein-binding agent with a unique mechanism of action, under investigation as a novel therapy for Wilson Disease.
  • September 2017, The French biotech, Vivet Therapeutics is developing the first gene therapy for Wilson’s disease. Seeing its potential, both the FDA and the EC have decided to grant orphan status to the treatment, which makes it easier and cheaper to get it approved if it proves to be safe and effective. The biotech is planning started the first clinical trial in late 2018.

 

Why Purchase the Report?

• Visualize the composition of the global Wilson’s disease treatment market across each indication, in terms of type and treatment options, highlighting the critical commercial assets and players.

• Identify business opportunities in global Wilson’s disease treatment market by analyzing trends and co-development deals.

• Excel data sheet with thousands of data points of the global Wilson’s disease treatment market – level 4/5 segmentation.

• PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

• Product mapping in excel for the principal products of all major market players

 

Who can benefit from this report?

• Equipment Suppliers/ Buyers

• Service Providers/ Buyers

• Industry Investors/Investment Bankers

• Education & Research Institutes

• Research Professionals

• Emerging Companies

• Manufacturers

 1. Wilsons Disease Treatment Market Scope and Methodology

1.1. Research Methodology

1.2. Scope of the market

 

2. Wilsons Disease Treatment Market Trends

2.1. Key Trends and Developments

 

3. Wilsons Disease Treatment Market Outlook

3.1. Drivers

3.2. Restraints

3.3. Supply Chain Analysis

3.4. Epidemiology

3.5. Key Developments

 

4. Wilsons Disease Treatment Market Segmentation Analysis

4.1. By Indication

4.1.1. Hepatic

4.1.2. Neuropsychiatric

4.1.3. Ophthalmic

4.1.4. Others (heart and kidney complications)

4.2. By Treatment

4.2.1. Medications

4.2.1.1. D-Penicillamine

4.2.1.2. Trientine

4.2.1.3. Zinc

4.2.1.4. Tetrathiomolybdate

4.2.5. Others

4.3. By Distribution Channel

4.3.1. Hospitals

4.3.2. Clinics

4.3.3. Others

 

5. Regional, Country-level Analysis

5.1. Geographic Overview

5.2. North America

5.2.1. The U.S.

5.2.2. Canada

5.2.3. Mexico

5.3. Europe

5.3.1. Germany

5.3.2. U.K.

5.3.3. France

5.3.4. Rest of Europe

5.4. South America

5.4.1. Brazil

5.4.2. Argentina

5.4.3. Rest of South America

5.5. Asia Pacific

5.5.1. China

5.5.2. India

5.5.3. Japan

5.5.4. Australia

5.5.5. Rest of Asia Pacific

5.6. Rest of World

 

6. Wilsons Disease Treatment Market Competitive Analysis

6.1. Competitive Scenario

6.2. Key Strategies adopted by Manufacturers

6.3. Product Benchmarking

 

7. Wilsons Disease Treatment Market Company Profiles

7.1. Tsumura & Co

7.2. Merck

7.3. VHB Life Science Inc.

7.4. Teva Pharmaceuticals

7.5. Alexion Pharmaceuticals (Wilson’s Therapeutics AB)

7.6. Noble Pharma Co., Ltd

7.7. Kadmon Holding, Inc.

7.8. Taj Pharmaceutical Limited

7.9. Vivet Therapeutics

 

8. Wilsons Disease Treatment Market Appendix

8.1. Sources

8.2. List of Tables

8.3. Expert Panel Validation

8.4. Disclaimer

8.5. Contact Us

Buy This Report



Could not find what you need?

Quick Fact: 7 of 10 customers Tailor their reports

DMI Cognizance Expertise

Massive Repository

10-year historic data for 1000+ markets

Association Networks

Ground-Zero understanding of the market with inputs from relevant industry association members

First Hand Understanding

Tailored interviews with manufacturers, buyers, sellers, distributers and retailers for five-frame understanding of the market

360 Web Research

Analysis of publicly available white label papers, news announcements, press releases, financial reports and reliable paid consulting data

Star Expert Review

7-step data formulation for market analysis and forecasts, under thorough scrutiny of industry-specific consultants with over 20+ years of expertise

INSTANT DELIVERY - 20% OFF

Global Voice Restoration Devices Market – Size, Share and Forecast (2018 – 2025)

Global Breast Implant Market – Size, Share and Forecast (2018 – 2025)

Global Continuous Glucose Monitoring Market – Size, Share and Forecast (2019 – 2026)

Global Tabular Alumina Market – Size, Share and Forecast (2019-2025)

Global Continuous Passive Movement Market – Size, Share and Forecast (2019-2026)

Europe Specialty Tires Market – Size, Share and Forecast (2019-2026)

Europe Phase Change Material Market – Size, Share and Forecast (2019-2026)

Global Forage Seed Market – Size, Share and Forecast (2018-2025)

Global Bio-lubricants market – Size, Trends, Share and Forecast (2018-2025)

Global Genome Editing Market – Size, Share and Forecast (2018-2025)

Global Perlite Market – Size, Share and Forecast (2018-2025)

Global Diagnostic Imaging Market – Size, Share and Forecast (2018-2025)

Indonesia Flexible Packaging Market – Size, Share and Forecasts (2018-2025)

Global Fiber Cement Market – Size, Share and Forecast (2019-2026)

Global Hematology Market – Size, Share and Forecast ( 2018-2025 )

Global Utility Tractor Market – Size, Share and Forecast (2018 – 2025)

Global Smart Transformers Market – Size, Share and Forecast ( 2018 – 2025 )

Global Carbon Nanotubes Market – Size, Share and Forecast (2019-2026)

Global Food & Beverage Processing Equipment Market – Size, Share and Forecast (2018 – 2025)

Europe Construction Chemicals Market – Size, Share and Forecast (2018 – 2025)

Global Powered Exoskeleton Market – Size, Share and Forecast (2018-2025)

Global Desalination Market – Size, Share and Forecast (2018-2025)

Global Advanced Wound Care Market – Size, Share and Forecast (2018-2025)

Global Agrifood Blockchain Market – Size, Share and Forecast (2018-2025)

Global Bio fuels Market – Size, Share and Forecast (2018-2025)

Global Flexible Packaging Market – Size, Share and Forecast (2018-2025)

Global Hydrogen Cyanide Market – Size, Share and Forecast (2018-2026)

Global Companion Animal Health Market – Forecasts 2018-2025

Global Agricultural Tires Market – Size, Share and Forecast ( 2018-2025 )

Global Combined Heat and Power Market – Size, Share and Forecast (2018-2025)

Global Hemodialysis Market – Size, Share and Forecast (2018-2025)

Global Service Robotics Market – Size, Share and Forecast (2018-2025)

Global Closed System Drug Transfer Devices Market – Size, Share and Forecast (2018-2025)

Global 3D Printed Electronics Market – Size, Share and Forecast (2018-2025)

Global Feed Phosphate Market – Size, Share and Forecast (2019-2026)

Brazil Renal Dialysis Equipment Market – Size, Share and Forecast (2019-2026)

Global Cable Glands Market – Size, Share and Forecast (2019-2026)

Brazil Companion Animal Health Market – Size, Share and Forecast (2019-2026)

Global Diabetic Foot Ulcers Market – Size, Share and Forecasts (2019-2026)

Global Prostate Cancer Market – Size, Share and Forecasts (2019-2026)

Global Fetal Neonatal Monitoring Market – Size, Share and Forecast (2019-2026)

Global Stevia Market – Size,Share and Forecasts (2018-2025)

Brazil Diagnostic Imaging Market – Size, Share and Forecasts (2019-2026)

Philippines Contact Cement Market – Size, Share and Forecasts (2018-2025)

Global Central Venous Catheters Market – Size, Share and Forecast (2018-2025)

Global Atopic Dermatitis Market – Size, Share and Forecast (2018-2025)

Advanced Driver Assistance Systems Market – Size, Share and Forecast (2018-2025)

Global Oncolytic Virus Therapy Market – Size, Share and Forecast (2019-2026)

Global Diesel Generator Market – Size, Share and Forecast (2018-2025)

Global Animal Feed Additives Market – Size,Share and Forecast (2018-2025)

Agricultural Testing Market – Size, Share and Forecast (2018-2025)

Global Polyvinyl Chloride Market – Size, Share and Forecasts (2018-2025)

Plant Bio-Stimulants Market – Size, Share and Forecast (2018-2025)

Global Construction Chemicals Market – Size, Share and Forecasts (2018-2025)

Global Plant Proteins Market – Size, Share and Forecast (2018-2025)

Global Dairy Protein Market – Size, Share and Forecast (2018-2025)

Global Freeze-Dried Food Market – Size, Share and Forecasts (2018-2025)

Global Pet Food Market – Size, Share and Forecasts (2018-2025)

Global Respiratory Devices Market – Size, Share and Forecasts (2018-2025)

Global Pediatric Clinical Trails Market – Size, Share and Forecast (2018-2025)

Global ECG Market – Size, Share and Forecast (2018-2025)

Global Companion Diagnostics Market – Size, Share and Forecast (2018-2025)

Global Molecular Diagnostics Market – Size, Share and Forecast (2018-2025)

Food & Feed Testing and Certification – Size, Share and Forecast (2018-2025)

Global Active Pharmaceutical Ingredients Market – Size, Share and Forecast (2018-2025)

South America Companion Animal Healthcare Market – Size, Share and Forecast (2018-2025)

India Agriculture and Construction Equipment Market – Size, Share and Forecast (2019-2026)

Lubricants Market – Size,Share and Forecasts (2019-2026)

Global Graphene Market – Size, Share and Forecast (2019-2026)

Brazil Agricultural and Construction Equipment Market – Size, Share and Forecast (2019-2026)

Global Carbon Black Market – Size, Share and Forecasts (2019-2026)

China Companion Animal Health Market – Size, Share and Forecast (2018-2025)

India Truck and Bus Market – Size, Share and Forecast (2019-2026)

Brazil Truck & Bus Market – Size, Share and Forecast (2019-2026)

Global Photonics Market – Size, Share and Forecast (2019-2026)

Romania Agricultural Tractor Machinery Market – Size, Share and Forecast (2019-2026)

Inflight Catering Services – Size, Share and Forecast (2018-2025)

Global Arthroscopy Devices Market – Size, Share and Forecast (2018 – 2025)

Copyright © 2019 DataM Intelligence. All Rights Reserved

Designed and Developed by -Montaigne Labs